Assessment of Hepatic Arterial Infusion of Floxuridine With Systemic Gemcitabine and Oxaliplatin

This phase 2 clinical trial evaluates the use of hepatic arterial infusion of floxuridine plus systemic administration of gemcitabine and oxaliplatin in patients with unresectable intrahepatic cholangiocarcinoma.

Read the full article here

Related Articles